November 10, 2023 05:41 AM ESTUpdated 06:11 AM
Peer Review

Cen­tu­ry Ther­a­peu­tics nabs Bris­tol My­ers alum as CEO; En­her­tu star Dai­ichi Sankyo makes changes in Eu­rope

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Cen­tu­ry Ther­a­peu­tics an­nounced the de­par­ture of CEO La­lo Flo­res in April, and the Philadel­phia cell ther­a­py biotech has found his …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times